Claritin and Rifadin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Claritin and Rifadin together.

The phase IV clinical study analyzes what interactions people who take Claritin and Rifadin have. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 26, 2023

5 people who take Claritin and Rifadin together, and have interactions are studied.


What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 71,110 Claritin users for its effectiveness, alternative drugs and more.

What is Rifadin?

Rifadin has active ingredients of rifampin. eHealthMe is studying from 2,030 Rifadin users for its effectiveness, alternative drugs and more.

Number of Claritin and Rifadin reports submitted per year:

Claritin and Rifadin drug interactions.

Common Claritin and Rifadin drug interactions by gender *:

female:

  1. Cognitive disorder

male:

  1. Drug ineffective
  2. Areflexia
  3. Diabetes mellitus
  4. Diabetic neuropathy
  5. Dizziness
  6. Dysarthria
  7. Dyskinesia
  8. Emotional disorder
  9. Extrapyramidal disorder
  10. Gait disturbance

Common Claritin and Rifadin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Azotaemia
  2. Death
  3. Drug ineffective
  4. Hepatic cancer metastatic
  5. Lung cancer metastatic
  6. Metabolic acidosis
  7. Pancreatic neuroendocrine tumour
  8. Renal failure acute

50-59:

  1. Areflexia
  2. Dizziness
  3. Dysarthria
  4. Dyskinesia
  5. Emotional disorder
  6. Extrapyramidal disorder
  7. Gait disturbance
  8. Hypoaesthesia
  9. Injury
  10. Muscle atrophy

60+:

  1. Cognitive disorder

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and Rifadin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Claritin and Rifadin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Claritin side effects:

Browse all side effects of Claritin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rifadin side effects:

Browse all side effects of Rifadin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Claritin interactions:

Browse all interactions between Claritin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rifadin interactions:

Browse all interactions between Rifadin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine and rifampin (the active ingredients of Claritin and Rifadin, respectively), and Claritin and Rifadin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Claritin and Rifadin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: